Ostrowski SR - Search Results

1

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis.

Hindy G, Tyrrell DJ, Vasbinder A, Wei C, Presswalla F, Wang H, Blakely P, Ozel AB, Graham S, Holton GH, Dowsett J, Fahed AC, Amadi KM, Erne GK, Tekmulla A, Ismail A, Launius C, Sotoodehnia N, Pankow JS, Thørner LW, Erikstrup C, Pedersen OB, Banasik K, Brunak S, Ullum H, Eugen-Olsen J, Ostrowski SR; DBDS Consortium; Haas ME, Nielsen JB, Lotta LA; Regeneron Genetics Center; Engström G, Melander O, Orho-Melander M, Zhao L, Murthy VL, Pinsky DJ, Willer CJ, Heckbert SR, Reiser J, Goldstein DR, Desch KC, Hayek SS. Hindy G, et al. Among authors: ostrowski sr. J Clin Invest. 2022 Dec 15;132(24):e158788. doi: 10.1172/JCI158788. J Clin Invest. 2022. PMID: 36194491 Free PMC article.

2

Impaired production of cytokines is an independent predictor of mortality in HIV-1-infected patients.

Ostrowski SR, Gerstoft J, Pedersen BK, Ullum H. Ostrowski SR, et al. AIDS. 2003 Mar 7;17(4):521-30. doi: 10.1097/00002030-200303070-00007. AIDS. 2003. PMID: 12598772

3

A low level of CD4+CD28+ T cells is an independent predictor of high mortality in human immunodeficiency virus type 1-infected patients.

Ostrowski SR, Gerstoft J, Pedersen BK, Ullum H. Ostrowski SR, et al. J Infect Dis. 2003 Jun 1;187(11):1726-34. doi: 10.1086/375239. Epub 2003 May 15. J Infect Dis. 2003. PMID: 12751030

4

Soluble urokinase receptor levels in plasma during 5 years of highly active antiretroviral therapy in HIV-1-infected patients.

Ostrowski SR, Katzenstein TL, Piironen T, Gerstoft J, Pedersen BK, Ullum H. Ostrowski SR, et al. J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):337-42. doi: 10.1097/00126334-200404010-00002. J Acquir Immune Defic Syndr. 2004. PMID: 15097149

5

Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells.

Ostrowski SR, Plomgaard P, Fischer CP, Steensberg AS, Møller K, Høyer-Hansen G, Pedersen BK, Ullum H. Ostrowski SR, et al. Scand J Immunol. 2005 Feb;61(2):197-206. doi: 10.1111/j.0300-9475.2005.01547.x. Scand J Immunol. 2005. PMID: 15683457 Free article.

6

Plasma concentrations of soluble urokinase-type plasminogen activator receptor are increased in patients with malaria and are associated with a poor clinical or a fatal outcome.

Ostrowski SR, Ullum H, Goka BQ, Høyer-Hansen G, Obeng-Adjei G, Pedersen BK, Akanmori BD, Kurtzhals JA. Ostrowski SR, et al. J Infect Dis. 2005 Apr 15;191(8):1331-41. doi: 10.1086/428854. Epub 2005 Mar 14. J Infect Dis. 2005. PMID: 15776381

7

High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients.

Ostrowski SR, Piironen T, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H. Ostrowski SR, et al. J Acquir Immune Defic Syndr. 2005 May 1;39(1):23-31. doi: 10.1097/01.qai.0000157950.02076.a6. J Acquir Immune Defic Syndr. 2005. PMID: 15851910

8

Reduced release of intact and cleaved urokinase receptor in stimulated whole-blood cultures from human immunodeficiency virus-1-infected patients.

Ostrowski SR, Piironen T, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H. Ostrowski SR, et al. Scand J Immunol. 2005 Apr;61(4):347-56. doi: 10.1111/j.1365-3083.2005.01582.x. Scand J Immunol. 2005. PMID: 15853918 Free article.

9

2B4 expression on natural killer cells increases in HIV-1 infected patients followed prospectively during highly active antiretroviral therapy.

Ostrowski SR, Ullum H, Pedersen BK, Gerstoft J, Katzenstein TL. Ostrowski SR, et al. Clin Exp Immunol. 2005 Sep;141(3):526-33. doi: 10.1111/j.1365-2249.2005.02869.x. Clin Exp Immunol. 2005. PMID: 16045743 Free PMC article.

10

Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy.

Ostrowski SR, Katzenstein TL, Pedersen M, Høyer-Hansen G, Gerstoft J, Pedersen BK, Ullum H. Ostrowski SR, et al. Scand J Immunol. 2006 Jun;63(6):478-86. doi: 10.1111/j.1365-3083.2006.001768.x. Scand J Immunol. 2006. PMID: 16764702 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

329 results

Search Page